Latest in Pharma 5.0

Unveiling the Agenda for the Chemspec Europe 2024’s Conferences

The conference includes talks from industry experts on AI, API synthesis, SCIP optimisation and the climate of the chemical industry

Find out more

Sartorius and Sanofi collaborate to commercialise end-to-end downstream process intensification platform

The agreement will see Sartorius commercialise Sanofi's ICB platform, which aims to enhance the efficiency of the drug manufacturing process
find out more

ArgusEye closes €2.8m funding to accelerate bioprocessing

The funding will support the development of the company's sensor system platform, Auga, which assists the efficient quantification of mAbs

CPI collaborates with industry leaders to expedite drug manufacturing via digitisation

Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process

Real-time data insights powered by digital transformation

The most trailblazing contract development and manufacturing organisations (CDMOs) are at the forefront of digital transformation, leveraging it to offer unparalleled customer service through operational streamlining and the provision of insights

The future of industrial automation in chemicals

The chemical industry is a large and diverse sector that manufactures a wide range of products, including fibres, plastics, surface finishes and pharmaceutical excipients. Agriculture, construction, transportation, healthcare and consumer goods are just a few sectors that use such chemical products

Implementing a “low/no code” automated process control system

Never before has the world seen such great progress in digital technology; we are at the forefront of breakthrough innovations, systems and processes that are facilitating the development of incredible products for our communities. Yet, with these advances, many companies in the life sciences and pharmaceutical industries are experiencing growth pains

Greener and smarter: positive post-pandemic effects in the laboratory sector

The widespread effects of the COVID-19 pandemic can be seen in almost all businesses globally, but not always negatively. According to a survey conducted by Starlab, improvements can be seen in the laboratory sector

Futureproofing pilot labs with OPC-UA technologies

Stephen Heffernan and Joanna Zolopa from AGI International, part of the AGI Group, discuss how the use of OPC-UA compliant technologies can help manufacturers to stay ahead of the curve and futureproof their pilot labs

Making the most of each cell: single-use perfusion in biopharma processing

GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing, reports Ruediger Goehmann, Product Manager, Pharma/Chemicals, at GEA Separators

Latest posts in Pharma 5.0

Resilient, flexible and forward-thinking: the future of contract manufacturing

As pharma and biotech companies face economic uncertainty and customer demand evolves, the contract development and manufacturing sector is in the midst of a transformation.

Revolutionising the life science industry with generative AI

Offering more effective and affordable drug development in a highly competitive market, generative AI can be used to increase revenue opportunities, drive value and improve patient outcomes with safer products

How digitalisation can create a more sustainable European chemicals industry

The European chemicals sector has a key role to play in building a more sustainable world and meeting the goals of the European Green Deal. Not only committed to making its own operations greener, it enables many downstream industries to reach their own sustainability targets and build circular economies throughout multiple sectors and ecosystems

Innovating pharma manufacturing starts with data at the edge

Adhering to strict regulations while enabling innovation can be a challenge; but, says Greg Hookings, Industry Director at Stratus Technologies, these hurdles can be overcome with real-time data

Maximising pharma’s data security with a layered defence system

The pharmaceutical landscape is changing rapidly. The demand for more affordable and effective medications is increasing and has prompted drug developers and manufacturers to adopt innovative techniques, information and operational technologies (IT/OT). Many are adopting an Industry 4.0 model, focusing on automation and data exchange to achieve operational excellence

A future manufacturing setup for Pharma 4.0

Developing autonomous manufacturing processes using benchtop crystallisers

Maximising data quality in digital PCR

Data forms the backbone of all scientific innovation, guiding researchers in their experimental direction and contributing to meaningful conclusions. Marwan Alsarraj, Biopharma Segment Manager, Digital Biology Group, at Bio-Rad reports

Beyond Pharma 4.0: pharma manufacturing and Industry 5.0

There’s a saying that the only constant in life is change. In terms of manufacturing technology, Industry 4.0 represents the most recent fundamental change, presenting a vision of smart manufacturing, near-complete automation, fully optimised processes and, ultimately, the “lights out” factory. Heather Coglaiti, Life Sciences Industry Leader, and Dan UpDyke, Strategic Marketing Manager at Rockwell Automation, report

The future of digital sample management

An unsung hero in the drug development process, proper biological sample management is fundamental to ensuring the accuracy and applicability of scientific studies. Dr Kevin Robinson (KSR) recently spoke to Steve Knight (SK), Commercial Director at Ziath, to learn more about the currently available technology, how it works and what the company is doing to improve the process for the researchers of today and tomorrow